News - Royalty Pharma
WEBAug 8, 2024 — Royalty Pharma Declares Third Quarter 2024 Dividend. Earnings. NEW YORK, NY, July 17, 2024 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of …
Royalty Pharma Highlights Accomplishments and Provides …
WEBJan 8, 2024 — Royalty Pharma plc. 2023 Portfolio Receipts expected to be approximately $3,050 million, exceeding the upper end of guidance range. Announced transactions of $13 billion since 2020 expected to...
Royalty Pharma plc (RPRX) Latest Stock News & Headlines - Yahoo …
WEBGet the latest Royalty Pharma plc (RPRX) stock news and headlines to help you in your trading and investing decisions.
Royalty Pharma plc (RPRX) - Yahoo Finance
WEBFind the latest Royalty Pharma plc (RPRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
FDA Approves KarXT To Treat Schizophrenia; PureTech
WEB14 hours ago — Royalty Pharma had acquired an interest in PureTech's royalty in KarXT. PureTech is also entitled to get additional future milestone payments and about 2 percent royalty on annual sales over $2 ...
Royalty Pharma
WEBRoyalty Pharma Reports Second Quarter 2024 Results. Earnings. NEW YORK, NY, August 8, 2024 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2024 and raised full year 2024 guidance for Portfolio Receipts.
Royalty Pharma Highlights Accomplishments and ... - Markets Insider
WEBNEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today provided an update on its business performance, including recent key accomplishments, and the full year 2023...
RPRX Stock Price | Royalty Pharma PLC Stock Quote (U.S.: Nasdaq ...
WEBSep 18, 2024 — RPRX | Complete Royalty Pharma PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
PureTech-Invented KarXT Receives U.S. Food and Drug …
WEB21 hours ago — PureTech’s monetization of equity holdings in Karuna, including gross proceeds from the BMS acquisition of Karuna, and a strategic royalty agreement with Royalty Pharma have enabled PureTech to ...
Royalty Pharma plc (RPRX) Stock Price, Quote, News & Analysis
WEB4 days ago — A high-level overview of Royalty Pharma plc (RPRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Some results have been removed